Last update 05 Mar 2025

HRS-8179

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HRS 8179, HRS-8179, HRS8179
Target
SUR1
Mechanism
SUR1 inhibitors(Sulfonylurea receptor 1 inhibitors)
Therapeutic Areas
Nervous System DiseasesCardiovascular Diseases
Active Indication
Brain EdemaBrain Infarction
Inactive Indication-
Originator Organization
Beijing Suncadia Pharmaceuticals Co., Ltd
Active Organization
Beijing Suncadia Pharmaceuticals Co., Ltd
Inactive Organization-
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with HRS-8179
NCT06732648
/ RecruitingPhase 2/3
The Efficacy and Safety of Intravenous HRS8179 for the Prevention and Treatment of Severe Cerebral Edema Following Large Hemispheric Infarction: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II/III Clinical Trial
CTR20244719
/ RecruitingPhase 2/3
注射用HRS8179预防和治疗大脑半球大面积梗死后严重脑水肿的有效性及安全性研究—多中心、随机、双盲、安慰剂对照、II/Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase II/III clinical trial of HRS8179 for injection in preventing and treating severe cerebral edema after large-area cerebral infarction
NCT05690711
/ CompletedPhase 2
Efficacy and Safety of Intravenous HRS8179 on Brain Swelling After Large Hemispheric Infarction: a Randomised, Double-blind, Placebo-controlled Phase II Trial
100 Clinical Results associated with HRS-8179
Login to view more data
100 Translational Medicine associated with HRS-8179
Login to view more data
100 Patents (Medical) associated with HRS-8179
Login to view more data
100 Deals associated with HRS-8179
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain EdemaPhase 3
CN
Beijing Suncadia Pharmaceuticals Co., Ltd
07 Feb 2025
Brain InfarctionPhase 2
CN
Beijing Suncadia Pharmaceuticals Co., Ltd
07 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05690711 (HRS8179-201, Literature | NEWS)
ManualManual
Phase 2
Brain Edema
40
qbbhvleatx(jqwthvyasc) = fvgkopkiwa gytexifgzf (ekgxjtlhix )
View more
Positive
30 Jan 2025
Placebo
qbbhvleatx(jqwthvyasc) = fsqeotxwfx gytexifgzf (ekgxjtlhix )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free